You are here

pharmagather

Pharmagather

Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (Video)

Tuesday, August 6, 2024 - 6:30am

The Phasing Problem

In the Pipeline

Monday, August 5, 2024 - 7:56am

Mid-Year Hub Review: Five Considerations for Staying Ahead of the Curve

Friday, August 2, 2024 - 6:57am

Viral Vector Immunity

In the Pipeline

Friday, August 2, 2024 - 6:01am

The Acetonitrile Olympics

In the Pipeline

Tuesday, July 30, 2024 - 10:38pm

So Tell Me About This Idea of Yours Again

In the Pipeline

Tuesday, July 30, 2024 - 7:37am

Drug Channels News Roundup, July 2024: My $0.02 on FTC’s PBM Report, GoodRx & Humira, Averon = CVS + Cardinal, IRA vs. 340B, and My Favorite Chart

Tuesday, July 30, 2024 - 6:30am

Informa Connect’s Medicaid Drug Rebate Program Summit

Monday, July 29, 2024 - 6:00am

Crafting Effective, Patient-Centric Channel Strategies

Friday, July 26, 2024 - 6:30am

A New Way to Kill Bacteria

In the Pipeline

Thursday, July 25, 2024 - 6:54am

Protein Degradation in Focus

In the Pipeline

Wednesday, July 24, 2024 - 7:06am

Gross-to-Net Bubble Update: 2023 Pricing Realities at 10 Top Drugmakers

Tuesday, July 23, 2024 - 6:30am

Which Element is Greener, Anyway?

In the Pipeline

Monday, July 22, 2024 - 9:52pm

In the Heart of the Fraud

In the Pipeline

Monday, July 22, 2024 - 7:40am

Optimizing Product Commercialization in Today’s IDN Environment

Friday, July 19, 2024 - 7:23am

Prion Misfolding, In Detail

In the Pipeline

Thursday, July 18, 2024 - 7:37am

Too Much Delvin' Goin' On

In the Pipeline

Wednesday, July 17, 2024 - 7:01am

In the Pipeline

Tuesday, July 16, 2024 - 7:35am

PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating

Tuesday, July 16, 2024 - 7:30am

At the Breaking Point: The Unsustainable Future of Government Drug Discount Programs

Friday, July 12, 2024 - 7:26am

Pages